Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 71

DEA Research and Development Cultivation Supply Chain 71

Canna Law Blog

SEPTEMBER 1, 2020

Last week the Drug Enforcement Administration (DEA) issued a bad interim hemp rule. North Carolina attorney Rod Kight raised these concerns as well and he and I both spoke to Kyle Jaeger of Marijuana Moment about why we think are concerned about the DEA’s interim hemp rule. Weekly in a phone interview.

DEA 84

DEA Hemp Seed-To-Sale THC 84

Veriheal

JUNE 22, 2021

“Cannabis should remain illegal because more research is needed. We are not fully aware of the consequences of cannabis legalization because there are not enough studies to solidify its therapeutic uses” Yet the same individuals spewing this crap are the ones that stand in the way of progress.

DEA 59

DEA Access Therapy Cannabinoids 59

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Since then many different parties have tried to reschedule or end prohibition by filing petitions with DEA per the CSA protocol on rescheduling. That one was granted.

DEA 98

DEA Marijuana History Cannabis 98

Veriheal

DECEMBER 30, 2020

If you answered yes to these two questions, then the DEA might have the job for you. The Phoenix division of The Drug Enforcement Administration needs someone who can burn up a lot of cannabis products and other illegal substances. The DEA Says That This isn’t a Job Announcement . What about the bird’s man?

DEA 52

DEA Pharmaceutical Packaging Business 52

SMPL

APRIL 8, 2020

Epidiolex, the only plant-derived cannabis drug approved by the U.S. GW Pharmaceuticals, a biopharmaceutical company based in London, saw its stock go up 5.9% The expansion comes two years after the DEA first took Epidiolex off the most-restrictive class of controlled substances. on Tuesday, one day after the U.S.

DEA 40

DEA Epilepsy Pharmaceutical Food 40

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

NOVEMBER 17, 2022

This collaboration ensures first-of-their-kind consistent cannabinoid compositions for 575 DEA-licensed cannabis medical research institutions developing cures for PTSD, pain management, anxiety conditions and more Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp.

Research and Development 52

Research and Development Pharmaceutical DEA Cannabinoids 52

Canna Law Blog

AUGUST 31, 2023

This means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin. As an HHS spokesperson explained: “While HHS’s scientific and medical evaluation is binding on DEA, the scheduling recommendation is not. The AG could then reschedule.

DEA 116

DEA Marijuana Banking Research and Development 116

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ is confident that their pharmaceutical drugs will bring much needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington’s Disease.

DEA 66

DEA Clinical Trials THC Research and Development 66

Canna Law Blog

SEPTEMBER 6, 2023

The HHS news means that the country’s top health agency has finally conceded that cannabis has medical value, and isn’t a drug of abuse on par with fentanyl or heroin. If cannabis goes from a Schedule I to a Schedule III, the cannabis industry as we know it will forever change. if the plant is moved to Schedule III.

Research and Development 113

Research and Development DEA Marijuana Pharmaceutical 113

Cannabis Law Report

JUNE 29, 2021

PUBLISHER: CANNABIS LAW REPORT. Segra International completes first export of Cannabis plantlets from Canada to the USA. This shipment marks a tremendous milestone in the evolution of the US cannabis industry, as it represents one of the first imports of live Cannabis plants to a federally licensed US cultivator.

Research and Development 102

Research and Development DEA Supply Chain Pharmaceutical 102

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.”

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

Veriheal

JUNE 29, 2021

Some of the common therapeutics allowed under the Right to Try legislation include cannabis, psilocybin, MDMA, along with various other highly regulated or otherwise banned natural substances, as well as untested pharmaceutical formulations and various other therapies. A Push by Patients. Sunil Aggarwal was also named in the lawsuit.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

JULY 12, 2019

However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Another example of cannabinoid mono therapy is the THC pharmaceutical Marinol.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Cheri

DECEMBER 17, 2021

It is interesting to note that in all the media stories about the JAMA article, there were a multitude of caveats and warning intoned by researchers not to consider cannabis safe just because they found it was. Even though the JAMA study got significant media attention, it is nothing new under the sun.

Marijuana 246

Marijuana Media Patients DEA 246

Canna Law Blog

AUGUST 21, 2020

Although the Second Circuit expressed considerable skepticism of the drug scheduling regime, the court held that before plaintiffs could seek relief in federal court, they must first file a de-scheduling petition with the DEA. At this point, readers may be asking: Why didn’t the plaintiffs file a petition with the DEA? Petition at 3.

DEA 69

DEA Marijuana Pharmaceutical Cannabis 69

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. today announced a joint partnership with the intent to study the DNA sequence variation of three Clever Leaves’ cannabis cultivars as part of their Project Change Lives campaign.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Canna Law Blog

JULY 25, 2020

Like this, but with cannabis. But you might be surprised at the trending undercurrents within the Philippines regarding cannabis, even in light of Duterte’s strong stance against drugs. Cannabis has been in serious discussion in the Philippines congress since 2014. FDA and DEA in describing its reasoning for this position.

Supply Chain 98

Supply Chain DEA Legislation Hemp 98

Cannabis Law Report

DECEMBER 15, 2021

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). “With their track-record of working with the U.S. . About Mycrodose Therapeutics.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Canna Law Blog

AUGUST 25, 2020

The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!

DEA 89

DEA Therapy Decriminalization Pharmaceutical 89

SpeedWeed

JULY 23, 2021

This is the first time a research license for this type of work has been granted outside of state and city research licenses to study cannabis. . Thanks to the new DEA research license, MedPharm will now be able to supply investigational medications across state lines for the purpose of clinical trials.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Canna Law Blog

AUGUST 25, 2020

The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!

DEA 85

DEA Therapy Decriminalization Pharmaceutical 85

NewsMunchies

SEPTEMBER 5, 2018

Epidiolex , the first cannabis pharmaceutical to be approved by the U.S. Food and Drug Administration (DEA), contains the active ingredient cannabidiol (CBD) but it does not contain psychoactive molecule THC, which generates the marijuana high. “We and Sanofli are among the leading cannabis patent holders in Canada.

Supply Chain 40

Supply Chain DEA Pharmaceutical Chronic Pain 40

Cannabis Cheri

DECEMBER 17, 2021

It is interesting to note that in all the media stories about the JAMA article, there were a multitude of caveats and warning intoned by researchers not to consider cannabis safe just because they found it was. Even though the JAMA study got significant media attention, it is nothing new under the sun.

Marijuana 130

Marijuana Media Patients DEA 130

SpeedWeed

AUGUST 8, 2021

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . “It’s not just street cannabis put into a bottle,” GW Pharmaceutical CEO Justin Gover once told the Guardian.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

SpeedWeed

JULY 28, 2021

Colombian President Ivan Duque signed a decree on July 23, lifting a prohibition on exporting dried cannabis flower—and investors abroad are taking notice. . Decree 811 of 2021 modifies an earlier law that regulated the commercialization of medical cannabis, Justice Minister Wilson Ruiz said. million sq. A Safer Cash Crop for Colombia.

Legalization 52

Legalization Seed-To-Sale Pharmaceutical Research and Development 52

MedicalJane

MAY 14, 2020

Despite the fact that most states have legalized cannabis for medical use and the implications for health benefits are mounting, the federal government still has not legalized cannabis. The results suggest cannabis infused edibles may be particularly helpful for the symptoms and side effects associated with insomnia.

Sleep 95

Sleep Edibles DEA Policy 95

Cannabis Law Report

AUGUST 18, 2022

Among the first in the nation, Phillips Lytle’s Psychedelics Practice Team combines expertise in pharmaceutical science, FDA regulations and risk management to serve the legal needs of emerging bio-tech sectors. “It also creates new opportunities for researchers, entrepreneurs, investors and pharmaceutical companies.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. First up, cannabis has now been scientifically validated as a treatment for two severe forms of childhood epilepsy (more on this in a moment). The rollercoaster starts here!

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Cannabis Law Report

JULY 7, 2019

RE-PUBLISHED BY : CANNABIS LAW REPORT. Notwithstanding, this re-branding and imaging of cannabis, the basis for much of this confusion is the Controlled Substances Act. As a refresher, cannabis is classified as a “Schedule I” substance, which, defines it as a substance with no currently accepted medical use. De Ingeniis.

DEA 40

DEA Pharmaceutical Conditions Patients 40

Veriheal

MAY 4, 2022

If you search the term “cannabis and heart health” on Google, you’ll notice that the results are flooded with pages upon pages of claims about the plant’s allegedly negative impacts on cardiovascular health. Is the cannabis plant a true culprit for poor heart health ? But just how true are these claims?

Research and Development 98

Research and Development Consumption Vaping Edibles 98

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Canna Law Blog

JULY 2, 2022

On June 14, 2022, Harris Bricken attorneys Fred Rocafort, Jihee Ahn, Paul Coble, and Vincent Silwoski presented a webinar entitled Protecting, Monetizing and Enforcing Cannabis Intellectual Property. In this post, we will answer the cannabis patent questions that were not addressed in the webinar. delta-9-THC).

Extraction 69

Extraction Strains Conditions Cannabis 69

Veriheal

OCTOBER 23, 2020

And Virginia opens its very first medical cannabis dispensary . This is Lo with Veriheal keeping you up to date with the latest in cannabis news. While Democrats and Republicans remain divided on a number of issues, ending the War on Drugs and cannabis legalization seems to stand out as common ground amongst both parties. .

DEA 52

DEA Dispensary Programs Policy 52